Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Posters
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Home
/
Tags
/
checkpoint inhibitor therapy
checkpoint inhibitor therapy
| 4 min read
by
Stephanie DeMarco, PhD
Which clinical developments are cancer experts watching closely?
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.
News
| 4 min read
by
Michael Schubert, PhD
Sensitizing pancreatic cancer to immunotherapy
A new mouse study suggests that folinic acid treatment could help the immune system penetrate pancreatic cancer’s protective shell.
News
Available on Demand
The Impact of the Gut Microbiome on Cancer Immunotherapy Efficacy
The complex interplay between bacteria and the tumor microenvironment informs cancer immunotherapy strategies.
Webinars
Page 1 of 1 - 3 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Webinars
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Articles
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Compendium
Latest Issue
Volume 21 • Issue 1 • March 2025
March 2025
March 2025 Issue
Explore this issue